or Try an Advanced Search...

    Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.39 -1.45% -0.04
    ABOS closed down 1.45 percent on Monday, July 1, 2024, on 85 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical ABOS trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -1.45%
    MACD Bullish Signal Line Cross Bullish -1.45%
    Pocket Pivot Bullish Swing Setup -1.45%
    Volume Surge Other -1.45%
    Inside Day Range Contraction -1.45%
    Wide Bands Range Expansion -1.45%
    Up 3 Days in a Row Strength -1.45%
    Oversold Stochastic Weakness -1.45%
    Older End-of-Day Signals for ABOS ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 7 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 3% about 8 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    20 DMA Resistance about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ABOS Chart by TradingView
    Basic chart:

    Profile

    Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta

    Is ABOS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds?
    May 15 Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
    May 15 Q1 2024 Acumen Pharmaceuticals Inc Earnings Call
    May 14 Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript
    May 14 Acumen Pharmaceuticals GAAP EPS of -$0.25
    May 14 Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
    May 13 Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
    May 8 Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
    May 8 Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
    May 7 Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
    See more ABOS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.3099
    52 Week Low 1.8101
    Average Volume 399,992
    200-Day Moving Average 3.38
    50-Day Moving Average 3.02
    20-Day Moving Average 2.47
    10-Day Moving Average 2.31
    Average True Range 0.19
    RSI (14) 39.02
    ADX 37.88
    +DI 15.74
    -DI 25.59
    Chandelier Exit (Long, 3 ATRs) 2.58
    Chandelier Exit (Short, 3 ATRs) 2.66
    Upper Bollinger Bands 2.86
    Lower Bollinger Band 2.09
    Percent B (%b) 0.38
    BandWidth 31.09
    MACD Line -0.23
    MACD Signal Line -0.25
    MACD Histogram 0.0243
    Fundamentals Value
    Market Cap 138.12 Million
    Num Shares 57.9 Million
    EPS -1.11
    Price-to-Earnings (P/E) Ratio -2.15
    Price-to-Sales 538.78
    Price-to-Book 0.62
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.62
    Resistance 3 (R3) 2.62 2.55 2.58
    Resistance 2 (R2) 2.55 2.49 2.55 2.57
    Resistance 1 (R1) 2.47 2.46 2.43 2.46 2.55
    Pivot Point 2.40 2.40 2.38 2.39 2.40
    Support 1 (S1) 2.31 2.34 2.28 2.31 2.22
    Support 2 (S2) 2.24 2.30 2.24 2.20
    Support 3 (S3) 2.16 2.24 2.19
    Support 4 (S4) 2.15